ANWORTH MORTGAGE ASSET CORP Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016
ASSETS
Agency MBS pledged to counterparties at fair value
Agency MBS at fair value
Agency MBS
Non-Agency MBS
Total agency MBS at fair value
Paydowns receivable
Agency MBS
Non-Agency MBS
Total paydowns receivable

Available-for-sale Securities, Total
Agency MBS, Total
Non-Agency MBS at fair value
Agency MBS
Non-Agency MBS
Total non-Agency MBS at fair value
Residential mortgage loans held-for-securitization, net of allowance for credit losses of $56 and $0 at December 31, 2020 and December 31, 2019, respectively
Residential mortgage loans held-for-investment through consolidated securitization trusts, net for allowance of credit losses of $197 and $175 at December 31, 2020 and December 31, 2019, respectively
Residential real estate
Cash and cash equivalents
Reverse repurchase agreements
Restricted cash
Interest receivable
Loan principle receivables
Derivative instruments at fair value
Agency MBS
Total derivative instruments at fair value
Accounts receivable for sold Agency MBS
Receivables for MBS sold
Right to use asset - operating lease
Receivable for sold securities
Prepaid expenses and other assets
Total Assets

LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities:
Accrued interest payable
Repurchase agreements
Agency MBS
Non-Agency MBS
Total repurchase agreements
Warehouse line of credit
Asset-backed securities issued by securitization trusts
Junior subordinated notes
Derivative instruments at fair value
Agency MBS
Total derivative instruments at fair value
Warehouse line of credit payables
Derivative counterparty margin
Dividends payable on stock
Preferred Stock
Common Stock
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Common Stock

Payables for purchased Agency MBS
Payable for purchased loans
Agency MBS
Total payable for purchased loans
Payable for terminated swaps
Payable to counterparty
Accrued expenses and other liabilities
Long-term lease obligation
Total Liabilities

Series B Cumulative Convertible Preferred Stock: par value $0.01 per share; liquidating preference $25.00 per share ($19,494 and $19,494, respectively); 780 and 780 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively
Stockholders' Equity:
Cumulative Preferred Stock
Series A Preferred Stock
Series C Preferred Stock
Common Stock: par value $0.01 per share; authorized 200,000 shares, 99,242 and 98,849 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively
Additional paid-in capital
Accumulated other comprehensive income consisting of unrealized gains and losses
Accumulated deficit
Common Stock
Series A Preferred Stock
Series C Preferred Stock
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

Comments